Document

Blood Products Advisory Committee Advisory Committee; Notice of Meeting

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Blood Products Advisory Committee (the Committee). The general function o...

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Blood Products Advisory Committee (the Committee). The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues related to blood and products derived from blood. The meeting will be open to the public.

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

82 FR 52060

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Blood Products Advisory Committee Advisory Committee; Notice of Meeting,” thefederalregister.org (November 9, 2017), https://thefederalregister.org/documents/2017-24408/blood-products-advisory-committee-advisory-committee-notice-of-meeting.